Gordon Wong MD, Pedro S. Teixeira MD, Omar Sheikh MD, Mehdi H. Shishehbor DO, MPH, PhD
{"title":"Uncovering the Unexpected—True Lumen Compression by Subintimal Stent Causing Recurrent Acute Limb Ischemia for 15 Years: A Case Report","authors":"Gordon Wong MD, Pedro S. Teixeira MD, Omar Sheikh MD, Mehdi H. Shishehbor DO, MPH, PhD","doi":"10.1016/j.jscai.2026.105496","DOIUrl":"10.1016/j.jscai.2026.105496","url":null,"abstract":"<div><div>The mechanism of stent failure in acute limb ischemia includes a broad spectrum of thrombotic and mechanical factors. We present a patient with recurring Rutherford Class 2A acute limb ischemia, who underwent peripheral angiography demonstrating severe compression of the left superficial femoral artery true lumen by an old subintimal stent. This compression—the cause of recurring limb ischemia events over 15 years—was treated with side-by-side stenting of the true lumen. Diagnosed by fluoroscopy and intravascular ultrasound, true lumen compression by a subintimal stent is a rare mechanical complication of peripheral angioplasty and requires true lumen stenting for definitive management.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"5 8","pages":"Article 105496"},"PeriodicalIF":0.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148743755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jack Miller PhD, Tobias Bexten MD, Stefan Wiebe MD, Matthew Read MD, Trevor Simard MD, PhD, Suraj Yalamuri MD
{"title":"Augmented Reality Ultrasound-Guided Vascular Access via Apple Vision Pro","authors":"Jack Miller PhD, Tobias Bexten MD, Stefan Wiebe MD, Matthew Read MD, Trevor Simard MD, PhD, Suraj Yalamuri MD","doi":"10.1016/j.jscai.2026.105452","DOIUrl":"10.1016/j.jscai.2026.105452","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"5 8","pages":"Article 105452"},"PeriodicalIF":0.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148746006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Wei Wu PhD, Shijia Zhao PhD, Changkye Lee PhD, Yash Vardhan Trivedi MBBS, Farzad Rezaeicherati PhD, Ali Ghahremaninezhad PhD, Yiannis S. Chatzizisis MD, PhD
{"title":"Response to Letter to the Editor Regarding High-Definition Intravascular Ultrasound Versus Optical Coherence Tomography: Lumen Size and Plaque Morphology","authors":"Wei Wu PhD, Shijia Zhao PhD, Changkye Lee PhD, Yash Vardhan Trivedi MBBS, Farzad Rezaeicherati PhD, Ali Ghahremaninezhad PhD, Yiannis S. Chatzizisis MD, PhD","doi":"10.1016/j.jscai.2026.105525","DOIUrl":"10.1016/j.jscai.2026.105525","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"5 8","pages":"Article 105525"},"PeriodicalIF":0.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148746007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anja Øksnes MD, Akiko Maehara MD, PhD, Britt Engan MD, PhD, Vibeke Juliebø MD, PhD, Kalaivani Mahadevan MD, Kais Hyasat MD, Damien Collison MD, PhD, James Spratt MD, Ajay J. Kirtane MD, SM, Milada C. Hagen PhD, Svein Rotevatn MD, PhD, Tone Norekvål PhD, Øyvind Bleie MD, PhD, Margaret B. McEntegart MD, PhD
{"title":"The Morphological and Mechanistic Impact of an Investment Procedure on Coronary Chronic Total Occlusions","authors":"Anja Øksnes MD, Akiko Maehara MD, PhD, Britt Engan MD, PhD, Vibeke Juliebø MD, PhD, Kalaivani Mahadevan MD, Kais Hyasat MD, Damien Collison MD, PhD, James Spratt MD, Ajay J. Kirtane MD, SM, Milada C. Hagen PhD, Svein Rotevatn MD, PhD, Tone Norekvål PhD, Øyvind Bleie MD, PhD, Margaret B. McEntegart MD, PhD","doi":"10.1016/j.jscai.2026.105447","DOIUrl":"10.1016/j.jscai.2026.105447","url":null,"abstract":"<div><h3>Background</h3><div>During chronic total occlusion (CTO) percutaneous coronary intervention (PCI), a modification procedure is often performed after failure. Although this has been reported to improve subsequent procedural success, the anatomical impact and mechanism of benefit have never been systematically studied. The Invest-CTO study investigated whether a strategy of a planned 2-stage CTO PCI with upfront “investment” and staged “completion” procedure could improve procedural success and safety in high-risk CTO anatomy. In this analysis, we provide novel insights into the morphological and mechanistic impact of an upfront “investment procedure.”</div></div><div><h3>Methods</h3><div>This Invest-CTO substudy included the first 80 consecutive patients returning for completion of CTO PCI. Angiographic characteristics at baseline prior to investment were compared with those at the start of the completion procedures. Intravascular ultrasound was performed and analyzed after wire crossing during completion to identify changes in morphology.</div></div><div><h3>Results</h3><div>At the completion procedure, the overall median (IQR) J-CTO score decreased from 4 (3-4) to 2 (1.8-3), <em>P</em> < .001. The vessel was open in 28.8% (n = 23). Ambiguity of the proximal cap decreased from 77.5% to 12.5% (<em>P</em> < .001), and ambiguity of the vessel course decreased from 76.3% to 26.3% (<em>P</em> < .017). Median lesion length also decreased from 28.2 mm to 15 mm (<em>P</em> < .001). Three distinct modification patterns were defined by intravascular ultrasound: “intraplaque true-to-true communication” (n = 30), “extraplaque with fenestration”(n = 16), and “proximal cap modification” including hematoma resolution and healing of vessel injury (n = 34).</div></div><div><h3>Conclusions</h3><div>Performing a planned investment procedure reduced occlusion complexity, created fenestrations or facilitated intraplaque communication and wire crossing, or modified the antegrade track, facilitating subsequent dissection reentry in high-risk CTOs.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"5 8","pages":"Article 105447"},"PeriodicalIF":0.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148745974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Barry F. Uretsky MD, Srdjan B. Aleksandric MD, Srikanth Vallurupalli MD, Adib Chaus MD, Abdul Hakeem MD, James C. Blankenship MD, Yochai Birnbaum MD, Morton J. Kern MD
{"title":"Evaluation and Treatment of Myocardial Bridging by Clinical Phenotype","authors":"Barry F. Uretsky MD, Srdjan B. Aleksandric MD, Srikanth Vallurupalli MD, Adib Chaus MD, Abdul Hakeem MD, James C. Blankenship MD, Yochai Birnbaum MD, Morton J. Kern MD","doi":"10.1016/j.jscai.2026.105402","DOIUrl":"10.1016/j.jscai.2026.105402","url":null,"abstract":"<div><div>Myocardial bridging (MB), most commonly involving the left anterior descending artery, is an intramyocardial segment of a coronary artery traditionally regarded as a benign anatomical variant. However, in a subset of patients, MB has been implicated in anginal syndromes, myocardial infarction, and even sudden cardiac death. Most cases are asymptomatic and identified incidentally on coronary computed tomography or invasive angiography. Controversy surrounds best practices for management of this entity. This review summarizes current evidence in adult patients with isolated MB on the mechanisms producing ischemia and adverse cardiac outcomes, the value of testing modalities to diagnose ischemia, and treatment strategies based on the patient’s symptoms and clinical presentation (phenotype).</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"5 8","pages":"Article 105402"},"PeriodicalIF":0.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148746510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Michael C. Siah MD, Syed Muhammad Mashhood Ali Bokhari BS, Anahita Dua MD, Rick J. Powell MD, Steven Kum MD, Steven D. Abramowitz MD, Michiel Schreve MD, Daniel van den Heuvel MD, Dan G. Clair MD, Mehdi Shishehbor DO, Ucci Alessandro MD, Peter A. Schneider MD, Roberto Ferraresi MD
{"title":"A Hemodynamic Scoring System for Optimizing Transcatheter Arterialization of the Deep Veins in No-Option Patients With Chronic Limb-Threatening Ischemia","authors":"Michael C. Siah MD, Syed Muhammad Mashhood Ali Bokhari BS, Anahita Dua MD, Rick J. Powell MD, Steven Kum MD, Steven D. Abramowitz MD, Michiel Schreve MD, Daniel van den Heuvel MD, Dan G. Clair MD, Mehdi Shishehbor DO, Ucci Alessandro MD, Peter A. Schneider MD, Roberto Ferraresi MD","doi":"10.1016/j.jscai.2026.105503","DOIUrl":"10.1016/j.jscai.2026.105503","url":null,"abstract":"<div><h3>Background</h3><div>Transcatheter arterialization of the deep veins (TADV) with LimFlow (Stryker Peripheral Vascular) is an emerging revascularization strategy for patients with high-risk chronic limb-threatening ischemia (CLTI). Variability in outcomes highlights the need for structured tools to guide arteriovenous crossing-site selection and optimize perfusion. We propose an angiographic TADV scoring system to quantify the hemodynamic impact of donor artery selection and evaluate its association with clinical outcomes.</div></div><div><h3>Methods</h3><div>This retrospective analysis included 43 randomly selected patients from the PROMISE II trial with Rutherford class 5 to 6 no-option CLTI. Pre- and postprocedural angiograms were reviewed, and a TADV score (−4 to +4; lower scores indicating worse residual foot perfusion) was calculated by integrating below-the-knee arterial contribution with crossing-site selection. The primary outcome was change in ischemia-related pain. Secondary outcomes included limb salvage, amputation-free survival, wound healing, and secondary patency. Intraclass correlation coefficient assessed score reliability. Linear regression evaluated associations between TADV score and pain, and Cox regression assessed the relationship between pain and major amputation.</div></div><div><h3>Results</h3><div>Technical success was 100%. Mean pain decreased from 5.1 at baseline to 1.4 at 2 years, with median pain reaching 0 by 9 months. At 2 years, limb salvage was 60.7%, amputation-free survival 35.9%, and complete wound healing 62.5%. Intraclass correlation coefficient for the TADV score was 91.7%. Higher TADV scores were associated with lower pain at 1 and 3 months. Each one-point increase in pain increased major amputation risk (hazard ratio, 1.20; 95% CI, 1.02-1.41).</div></div><div><h3>Conclusions</h3><div>The TADV score correlates with early pain reduction and amputation risk, supporting its potential role in optimizing crossing-site selection and outcomes in no-option CLTI.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"5 8","pages":"Article 105503"},"PeriodicalIF":0.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148746004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kevin Jin BS, Kelley Chen MD, Benjamin L. Magod MD, Zhiying Meng MS, Heather Byrd BS, Abigail S. Baldridge DrPH, Daniel J. Romary MD, MS, Benjamin H. Freed MD, Yasmin Raza MD, Maanasi Samant MD, Ruben Mylvaganam MD, Michael J. Cuttica MD, MS, S. Chris Malaisrie MD, Stephen F. Chiu MD, Daniel R. Schimmel MD, MS
{"title":"Safety and Feasibility of Same-Day Discharge After Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Single-Center Retrospective Study","authors":"Kevin Jin BS, Kelley Chen MD, Benjamin L. Magod MD, Zhiying Meng MS, Heather Byrd BS, Abigail S. Baldridge DrPH, Daniel J. Romary MD, MS, Benjamin H. Freed MD, Yasmin Raza MD, Maanasi Samant MD, Ruben Mylvaganam MD, Michael J. Cuttica MD, MS, S. Chris Malaisrie MD, Stephen F. Chiu MD, Daniel R. Schimmel MD, MS","doi":"10.1016/j.jscai.2026.105505","DOIUrl":"10.1016/j.jscai.2026.105505","url":null,"abstract":"<div><h3>Background</h3><div>Balloon pulmonary angioplasty (BPA) is increasingly used for patients with inoperable or residual chronic thromboembolic pulmonary hypertension. Overnight observation is the current standard practice. We evaluated the safety and feasibility of same-day discharge (SDD) after BPA at a contemporary US referral center.</div></div><div><h3>Methods</h3><div>We retrospectively analyzed consecutive chronic thromboembolic pulmonary hypertension patients undergoing BPA between 2018 and 2024. SDD was defined as discharge on the calendar day of BPA. The primary outcome was 30-day readmission or mortality; secondary outcomes included BPA-related complications. Predictors of SDD were assessed using mixed-effects logistic regression.</div></div><div><h3>Results</h3><div>Seventy-seven patients underwent 262 BPA procedures; 89 (34%) were followed by SDD. Patients selected for SDD had higher baseline 6-minute walk distance (356 vs 270 m; <em>P</em> = .010). SDD procedures were shorter (89 vs 101 minutes; <em>P</em> < .001) and associated with lower mean pulmonary artery pressure (28.5 vs 34.9 mm Hg; <em>P</em> < .001). Overall, 30-day complication rates were low (6/262, 2.3%), with no periprocedural deaths. Thirty-day readmission rates were similar between SDD and non-SDD procedures (7.9% vs 4.0%; <em>P</em> = .43). In multivariable analysis, higher 6-minute walk distance (odds ratio [OR], 1.66 per 100 m; <em>P</em> = .026), device closure (OR, 6.33; <em>P</em> = .028), and larger balloon size (OR, 1.44 per mm; <em>P</em> = .037) were associated with SDD, whereas initial BPA session (OR, 0.13; <em>P</em> < .001) and longer procedure duration (OR, 0.66 per 10 minutes; <em>P</em> < .001) were associated with admission.</div></div><div><h3>Conclusions</h3><div>Among patients meeting prespecified institutional eligibility criteria, SDD after BPA was feasible and not associated with increased 30-day adverse events. Structured SDD pathways guided by reproducible selection criteria may optimize resource utilization as BPA volumes continue to grow.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"5 8","pages":"Article 105505"},"PeriodicalIF":0.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148746005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Krishna S. Gajula MD, Shanmukh Sai Pavan Lingamsetty MD, Hrushikesh R. Pamreddy MD, Akshat Banga MBBS, MD, Sahas R. Jitta MD, Mohamed Doma MD, Krishna Cherukuri MD, Kash Vahdat MD, Eddison Ramsaran MD, Andrew M. Goldsweig MD, MS
{"title":"Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis","authors":"Krishna S. Gajula MD, Shanmukh Sai Pavan Lingamsetty MD, Hrushikesh R. Pamreddy MD, Akshat Banga MBBS, MD, Sahas R. Jitta MD, Mohamed Doma MD, Krishna Cherukuri MD, Kash Vahdat MD, Eddison Ramsaran MD, Andrew M. Goldsweig MD, MS","doi":"10.1016/j.jscai.2026.105446","DOIUrl":"10.1016/j.jscai.2026.105446","url":null,"abstract":"<div><h3>Background</h3><div>Atrial fibrillation (AF) is prevalent among patients undergoing transcatheter aortic valve replacement (TAVR) and increases risks of thromboembolism and bleeding with chronic anticoagulation. Concomitant left atrial appendage occlusion (LAAO) during TAVR may reduce long-term stroke and bleeding risks.</div></div><div><h3>Methods</h3><div>PubMed, Embase, and Cochrane databases were searched through May 2025 for studies comparing TAVR + LAAO versus TAVR + standard medical therapy in patients with atrial fibrillation. Random-effects models were used to pool risk ratios (RRs) or mean differences with 95% CIs.</div></div><div><h3>Results</h3><div>Four studies (2 randomized controlled trials, 2 observational; n = 563, mean age 82 years) were included; 279 patients (49.5%) underwent TAVR + LAAO. Thirty-day outcomes showed no differences in mortality (RR 0.91; 95% CI, 0.28-3.01), stroke/transient ischemic attack (RR 0.27; 95% CI, 0.04-1.66), or major bleeding (RR 0.27; 95% CI, 0.04-1.66). Over a 9.8-month to 2-year follow-up, all-cause mortality (RR 0.95; 95% CI, 0.68-1.32), cardiac death (RR 0.95; 95% CI, 0.60-1.50), stroke/transient ischemic attack (RR 1.33; 95% CI, 0.30-5.83), and major bleeding (RR 1.06; 95% CI, 0.71-1.59) remained similar. Contrast use and hospital length of stay were comparable.</div></div><div><h3>Conclusions</h3><div>Concomitant TAVR plus LAAO appears feasible, with no statistically significant differences in short-term outcomes versus TAVR plus standard medical therapy; however, certainty is low, and findings are hypothesis-generating, warranting larger randomized trials and prospective registries.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"5 8","pages":"Article 105446"},"PeriodicalIF":0.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148746250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cheuk Bong Ho MBBS, Shing Fung Chui MBChB, Alan Ka Chun Chan MBBS, Michael Kang Yin Lee MBBS, Chi Yuen Wong MBBS
{"title":"Percutaneous Stenting of Interarterial Left Coronary Artery Followed by Transcatheter Aortic Valve Replacement","authors":"Cheuk Bong Ho MBBS, Shing Fung Chui MBChB, Alan Ka Chun Chan MBBS, Michael Kang Yin Lee MBBS, Chi Yuen Wong MBBS","doi":"10.1016/j.jscai.2026.105444","DOIUrl":"10.1016/j.jscai.2026.105444","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"5 8","pages":"Article 105444"},"PeriodicalIF":0.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148746513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Apoorva Sharma MD, Khansa Ahmad MD, Shea E. Hogan MD, MSCS
{"title":"Parity in Patency? Efficacy of Resorbable Scaffold by Sex in LIFE-BTK","authors":"Apoorva Sharma MD, Khansa Ahmad MD, Shea E. Hogan MD, MSCS","doi":"10.1016/j.jscai.2026.105492","DOIUrl":"10.1016/j.jscai.2026.105492","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"5 8","pages":"Article 105492"},"PeriodicalIF":0.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148743754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}